Real-world clinical performance of commercial SARS-CoV-2 rapid antigen tests in suspected COVID-19: A systematic meta-analysis of available data as per November 20, 2020

Johannes Hayer, Dusanka Kasapic, Claudia Zemmrich
doi: https://doi.org/10.1101/2020.12.22.20248614

Article Information

doi 
https://doi.org/10.1101/2020.12.22.20248614
History 
  • December 24, 2020.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.

Author Information

  1. Johannes Hayer1,
  2. Dusanka Kasapic2 and
  3. Claudia Zemmrich2,3,*
  1. 1Roche Diagnostics GmbH, Mannheim, Germany
  2. 2Roche Diagnostics International Ltd. Rotkreuz, Switzerland
  3. 3Institute for Pharmacology and Preventive Medicine, Menzelstrasse 21, 15831 Mahlow, Germany
  1. ↵*Corresponding author:
    Claudia Zemmrich, claudia.zemmrich{at}ippmed.de
Back to top
Posted December 24, 2020.
Download PDF
Data/Code
Email
Real-world clinical performance of commercial SARS-CoV-2 rapid antigen tests in suspected COVID-19: A systematic meta-analysis of available data as per November 20, 2020
Johannes Hayer, Dusanka Kasapic, Claudia Zemmrich
medRxiv 2020.12.22.20248614; doi: https://doi.org/10.1101/2020.12.22.20248614
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area